hypertension
Conditions
Interventions
Health guidance for people with high blood pressure and high blood pressure
Sponsors
The University of Osaka
NTT precision medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Employees belonging to the NTT Group who have already received Illumina's Infinium Asian Screening Array and have genetic polymorphism data with their consent. 2 Persons whose blood pressure at the time of medical examination and home blood pressure are higher than high blood pressure, or who have grade I hypertension, based on the 2019 Hypertension Treatment Guidelines 3 Persons who are over 40 years old and under 65 years old at the time of obtaining consent 4 Persons who have given written consent to participate in the research
Exclusion criteria
Exclusion criteria: 1 Persons who are pregnant or breastfeeding 2 Persons with a serious illness that requires immediate treatment 3 Other persons deemed unsuitable by the research director, co-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure reduction after health guidance due to hypertension-related gene polymorphisms | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in salt intake, Na/K ratio, body weight, etc. after health guidance for each hypertension-related gene polymorphism | — |
Countries
Japan
Contacts
Public ContactKei Kamide
The University of Osaka Graduate School of Medicine Department of Health Promotion Science, Division of Health Sciences
Outcome results
None listed